IDEXX Laboratories Inc. logo

IDEXX Laboratories Inc. (IDXX)

Health Care
$556.69
+0.31%

1 article

Price chart

-0.7%Jun 3 – Aug 31
$526$561$596Jun 3Jul 2Jul 31Aug 31
Hover the chart for daily prices

IDEXX Laboratories Inc. (IDXX) overview

IDEXX Laboratories provides veterinary diagnostics and software. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

IDEXX Laboratories Inc. trades on the NasdaqGS under the ticker symbol IDXX. As of the most recent market data, the stock was priced around $556.69, up 0.31% on the session, giving IDEXX Laboratories Inc. a market capitalization of roughly $43.86B.

Over the past 52 weeks, IDXX has traded between $518.55 and $769.98. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 39.1, a common gauge of how richly the market prices the company's earnings.

Key statistics

Price
$556.69
Change (1d)
+0.31%
Market cap
$43.86B
P/E ratio
39.1
52-week range
$518.55 – $769.98
Day range
$543.60 – $561.24
Volume
673.6K

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Why investors watch IDXX

As one of the larger companies in the Health Care sector, IDEXX Laboratories Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch IDXX for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.

Market Mood

0 Bullish1 Neutral0 Bearish

Latest IDXX news

Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance
EarningsNeutral8/20/2026

Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance

In Q2 2026, Baron Focused Growth Fund achieved a 13.26% gain, compared to a 24.02% return for the Russell 2500 Growth Index. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a key holding, closed at $562.20 per share on August 19, 2026, with a market capitalization of $44.29 billion. IDEXX reported a one-month return of 4.23%, but its shares declined by 11.19% over the past 52 weeks. This information highlights the Fund's investment strategy focusing on industry leaders like IDEXX, demonstrating potential market resilience which may interest investors looking for growth in the healthcare sector.

Read More: Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance

More Health Care stocks

Frequently asked questions

Is IDEXX Laboratories Inc. in the S&P 500?

Yes. IDEXX Laboratories Inc. (IDXX) is a member of the S&P 500 index, classified in the Health Care sector.

What sector is IDXX in?

IDEXX Laboratories Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.

Where can I find the latest IDXX news?

This page collects recent IDEXX Laboratories Inc. (IDXX) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.

What is IDEXX Laboratories Inc.'s stock price?

As of the most recent market data, IDEXX Laboratories Inc. (IDXX) traded at approximately $556.69. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.

What is IDEXX Laboratories Inc.'s market cap?

IDEXX Laboratories Inc. has a market capitalization of roughly $43.86B, based on its most recent share price and shares outstanding.

What is IDXX's P/E ratio?

IDXX trades at a trailing price-to-earnings ratio of about 39.1. The P/E ratio compares a company's share price to its earnings per share.

New to investing?